カナダ - 英語 - Health Canada

novopharm limited - cyproterone acetate - tablet - 50mg - cyproterone acetate 50mg - other miscellaneous therapeutic agents

イスラエル - 英語 - Ministry of Health

bayer israel ltd - cyproterone acetate - tablets - cyproterone acetate 50 mg - cyproterone - cyproterone - for antiandrogen therapy in men: sexual disorders, inoperable prostatic carcinoma.

カナダ - 英語 - Health Canada

bdh inc. - cyproterone acetate - tablet - 50mg - cyproterone acetate 50mg - other miscellaneous therapeutic agents

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - cyproterone acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; maize starch; pregelatinised maize starch; lactose monohydrate; magnesium stearate; povidone - inoperable prostatic carcinoma. to suppress 'flare' with initial luteinising hormone releasing hormone (lhrh) analogue therapy; in long-term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.

マルタ - 英語 - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - cyproterone acetate - tablet - cyproterone acetate 50 milligram(s) - sex hormones and modulators of the genital system

イスラエル - 英語 - Ministry of Health

bayer israel ltd - cyproterone acetate - tablets - cyproterone acetate 50 mg - cyproterone - for antiandrogen therapy in men: sexual disorders, inoperable prostatic carcinoma.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - cyproterone acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; povidone; magnesium stearate - inoperable prostatic carcinoma. to suppress flare with initial luteinising hormone releasing hormone (lhrh) analogue therapy; in long-term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - cyproterone acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; povidone; magnesium stearate - inoperable prostatic carcinoma. to suppress flare with initial luteinising hormone releasing hormone (lhrh) analogue therapy; in long-term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

generics (uk) limited - cyproterone acetate ethinylestradiol - tablets - 2mg/35ug %v/v

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - cyproterone acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; povidone; magnesium stearate - inoperable prostatic carcinoma. to suppress flare with initial luteinising hormone releasing hormone (lhrh) analogue therapy; in long-term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.